| appearance as argument number 1 |
|
| (documentation Vyvanse EnglishLanguage "Lisdexamfetamine, sold under the brand name Vyvanse among others, is a medication that is a derivative of amphetamine. It is mainly used to treat attention deficit hyperactivity disorder (ADHD) in people over the age of five as well as moderate-to-severe binge eating disorder in adults. Lisdexamfetamine is taken by mouth. In the United Kingdom, it is usually less preferred than methylphenidate. Its effects generally begin within 2 hours and last for up to 14 hours. Common side effects of lisdexamfetamine include loss of appetite, anxiety, diarrhea, trouble sleeping, irritability, and nausea. Rare but serious side effects include mania, sudden cardiac death in those with underlying heart problems, and psychosis. It has a high potential for substance abuse per the DEA. Serotonin syndrome may occur if used with certain other medications. Its use during pregnancy may result in harm to the baby and use during breastfeeding is not recommended by the manufacturer. Lisdexamfetamine is a central nervous system (CNS) stimulant that works after being converted by the body into dextroamphetamine. Chemically, lisdexamfetamine is composed of the amino acid L-lysine, attached to dextroamphetamine. Lisdexamfetamine was approved for medical use in the United States in 2007. In 2018, it was the 82nd most commonly prescribed medication in the United States, with more than 10 million prescriptions. It is a Schedule II controlled substance in the United Kingdom and a Schedule II controlled substance in the United States.[from Wikipedia]") | Medicine.kif 3253-3277 | |
| (medicine Vyvanse ADHD) | Medicine.kif 3298-3298 | Lisdexamfetamine is medicine for attention deficit hyperactivity disorder |
| (subclass Vyvanse Lisdexamfetamine) | Medicine.kif 3969-3969 | Lisdexamfetamine is a subclass of lisdexamfetamine |
| (subclass Vyvanse Medicine) | Medicine.kif 3252-3252 | Lisdexamfetamine is a subclass of medicine |
| (subclass Vyvanse Stimulant) | Medicine.kif 3251-3251 | Lisdexamfetamine is a subclass of stimulant |
| appearance as argument number 2 |
|
|
| (termFormat EnglishLanguage Vyvanse "Vyvanse") | Medicine.kif 3970-3970 | |
| (termFormat EnglishLanguage Vyvanse "lisdexamfetamine") | Medicine.kif 3279-3279 |
|
Show full definition with tree view
Show simplified definition (without tree view)
Show simplified definition (with tree view)
|
|
Sigma web home Suggested Upper Merged Ontology (SUMO) web home
Sigma version 3.0 is open source software produced by Articulate Software and its partners